S&P 500   4,206.17 (+0.63%)
DOW   33,021.77 (+0.34%)
QQQ   349.87 (+0.54%)
AAPL   179.54 (+1.29%)
MSFT   329.05 (+0.20%)
META   269.06 (+1.64%)
GOOGL   123.00 (+0.11%)
AMZN   121.72 (+0.95%)
TSLA   204.25 (+0.16%)
NVDA   392.74 (+3.81%)
NIO   7.53 (+0.00%)
BABA   82.78 (+4.06%)
AMD   119.51 (+1.10%)
T   15.82 (+0.57%)
F   12.08 (+0.67%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.78%)
GE   104.27 (+2.70%)
DIS   88.06 (+0.11%)
AMC   4.62 (+2.67%)
PFE   38.09 (+0.18%)
PYPL   62.61 (+1.00%)
NFLX   400.52 (+1.34%)
S&P 500   4,206.17 (+0.63%)
DOW   33,021.77 (+0.34%)
QQQ   349.87 (+0.54%)
AAPL   179.54 (+1.29%)
MSFT   329.05 (+0.20%)
META   269.06 (+1.64%)
GOOGL   123.00 (+0.11%)
AMZN   121.72 (+0.95%)
TSLA   204.25 (+0.16%)
NVDA   392.74 (+3.81%)
NIO   7.53 (+0.00%)
BABA   82.78 (+4.06%)
AMD   119.51 (+1.10%)
T   15.82 (+0.57%)
F   12.08 (+0.67%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.78%)
GE   104.27 (+2.70%)
DIS   88.06 (+0.11%)
AMC   4.62 (+2.67%)
PFE   38.09 (+0.18%)
PYPL   62.61 (+1.00%)
NFLX   400.52 (+1.34%)
S&P 500   4,206.17 (+0.63%)
DOW   33,021.77 (+0.34%)
QQQ   349.87 (+0.54%)
AAPL   179.54 (+1.29%)
MSFT   329.05 (+0.20%)
META   269.06 (+1.64%)
GOOGL   123.00 (+0.11%)
AMZN   121.72 (+0.95%)
TSLA   204.25 (+0.16%)
NVDA   392.74 (+3.81%)
NIO   7.53 (+0.00%)
BABA   82.78 (+4.06%)
AMD   119.51 (+1.10%)
T   15.82 (+0.57%)
F   12.08 (+0.67%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.78%)
GE   104.27 (+2.70%)
DIS   88.06 (+0.11%)
AMC   4.62 (+2.67%)
PFE   38.09 (+0.18%)
PYPL   62.61 (+1.00%)
NFLX   400.52 (+1.34%)
S&P 500   4,206.17 (+0.63%)
DOW   33,021.77 (+0.34%)
QQQ   349.87 (+0.54%)
AAPL   179.54 (+1.29%)
MSFT   329.05 (+0.20%)
META   269.06 (+1.64%)
GOOGL   123.00 (+0.11%)
AMZN   121.72 (+0.95%)
TSLA   204.25 (+0.16%)
NVDA   392.74 (+3.81%)
NIO   7.53 (+0.00%)
BABA   82.78 (+4.06%)
AMD   119.51 (+1.10%)
T   15.82 (+0.57%)
F   12.08 (+0.67%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.78%)
GE   104.27 (+2.70%)
DIS   88.06 (+0.11%)
AMC   4.62 (+2.67%)
PFE   38.09 (+0.18%)
PYPL   62.61 (+1.00%)
NFLX   400.52 (+1.34%)
OTCMKTS:INNV

InnovAge (INNV) Stock Forecast, Price & News

$6.73
+0.40 (+6.32%)
(As of 05/31/2023 ET)
Compare
Today's Range
$6.06
$6.84
50-Day Range
$5.74
$7.98
52-Week Range
$3.39
$8.15
Volume
19,802 shs
Average Volume
17,575 shs
Market Capitalization
$912.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.25

INNV stock logo

About InnovAge (OTCMKTS:INNV) Stock

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. As of June 30, 2022, it served approximately 6,650 PACE participants in the United States; and operates 18 PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

INNV Stock News Headlines

Recap: InnovAge Holding Q3 Earnings
AI is Unstoppable. Now Is The Time!
AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.
What Wall Street expects from InnovAge's earnings
The $193 Billion US-China War You Don't Know About
They're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.
See More Headlines

INNV Price History

INNV Company Calendar

Last Earnings
5/09/2023
Today
6/01/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:INNV
Previous Symbol
NASDAQ:INNV
Fax
N/A
Employees
2,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.25
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+7.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-6,520,000.00
Pretax Margin
-7.63%

Debt

Sales & Book Value

Annual Sales
$698.64 million
Cash Flow
$0.09 per share
Book Value
$2.30 per share

Miscellaneous

Free Float
135,291,000
Market Cap
$912.79 million
Optionable
Not Optionable
Beta
-0.01

Key Executives

  • Mr. Patrick Blair (Age 52)
    Pres & CEO
    Comp: $1.48M
  • Ms. Barbara K. Gutierrez CPA (Age 60)
    Chief Financial Officer
    Comp: $625.45k
  • Ms. Nicole D'Amato (Age 44)
    Chief Legal Officer & Corp. Sec.
    Comp: $683.95k
  • Mr. Edward Moore Kennedy Jr. (Age 62)
    J.D., Independent Director
    Comp: $100k
  • Hon. Marilyn Barbour Tavenner M.H.A. (Age 72)
    R.N., Independent Director
    Comp: $120k
  • Ms. Maria Lozzano (Age 43)
    Chief Operating Officer
  • Mr. Ryan Kubota
    Director of Investor Relations
  • Ms. Olivia Patton
    Chief Compliance Officer
  • Ms. Robin Doerr (Age 59)
    Chief Sales & Marketing Officer
  • Mr. Rob Borella
    Chief Sales & Marketing Officer













INNV Stock - Frequently Asked Questions

Should I buy or sell InnovAge stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InnovAge in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" INNV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INNV, but not buy additional shares or sell existing shares.
View INNV analyst ratings
or view top-rated stocks.

What is InnovAge's stock price forecast for 2023?

3 Wall Street research analysts have issued 12 month price targets for InnovAge's stock. Their INNV share price forecasts range from $5.00 to $9.00. On average, they anticipate the company's stock price to reach $7.25 in the next twelve months. This suggests a possible upside of 7.7% from the stock's current price.
View analysts price targets for INNV
or view top-rated stocks among Wall Street analysts.

How have INNV shares performed in 2023?

InnovAge's stock was trading at $7.18 at the beginning of the year. Since then, INNV shares have decreased by 6.3% and is now trading at $6.73.
View the best growth stocks for 2023 here
.

How were InnovAge's earnings last quarter?

InnovAge Holding Corp. (OTCMKTS:INNV) posted its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.05) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.05). The firm earned $172.54 million during the quarter, compared to the consensus estimate of $174.54 million. InnovAge had a negative net margin of 6.17% and a negative trailing twelve-month return on equity of 13.04%.

What other stocks do shareholders of InnovAge own?
What is InnovAge's stock symbol?

InnovAge trades on the OTCMKTS under the ticker symbol "INNV."

Who are InnovAge's major shareholders?

InnovAge's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (0.94%), Geode Capital Management LLC (0.31%), Cambiar Investors LLC (0.23%), Renaissance Technologies LLC (0.09%), Martingale Asset Management L P (0.04%) and ExodusPoint Capital Management LP (0.03%). Insiders that own company stock include Edward Moore Jr Kennedy, Maureen Hewitt and Thomas Scully.
View institutional ownership trends
.

How do I buy shares of InnovAge?

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InnovAge's stock price today?

One share of INNV stock can currently be purchased for approximately $6.73.

How much money does InnovAge make?

InnovAge (OTCMKTS:INNV) has a market capitalization of $912.79 million and generates $698.64 million in revenue each year. The company earns $-6,520,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis.

How many employees does InnovAge have?

The company employs 2,000 workers across the globe.

How can I contact InnovAge?

InnovAge's mailing address is 8845 Rehco Road, San Diego CA, 92121. The official website for the company is www.innovuspharma.com. The company can be reached via phone at 844-803-8745 or via email at ir@innovuspharma.com.

This page (OTCMKTS:INNV) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -